Page last updated: 2024-08-17

17-alpha-hydroxyprogesterone and beta-Thalassemia

17-alpha-hydroxyprogesterone has been researched along with beta-Thalassemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahl, KD; Giordano, G; Giusti, M; Guido, R; McGuinness, D; Mori, PG; Valenti, S1

Trials

1 trial(s) available for 17-alpha-hydroxyprogesterone and beta-Thalassemia

ArticleYear
Delayed puberty in males with beta-thalassemia major: pulsatile gonadotropin-releasing hormone administration induces changes in gonadotropin isoform profiles and an increase in sex steroids.
    European journal of endocrinology, 1995, Volume: 133, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; beta-Thalassemia; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Estradiol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Hydroxyprogesterones; Immunoradiometric Assay; Isomerism; Luteinizing Hormone; Male; Pituitary Gland; Puberty, Delayed; Pulsatile Flow; Radioimmunoassay; Testis; Testosterone

1995